Abstract
The chronic heart failure is an outcome of many cardiovascular diseases and is characterized by a progressing current and the adverse forecast. The modern medicine for this group of patients offers the following types of treatment: heart transplantation, resinсhronization therapy. Now heart transplantation strongly took a place in an arsenal of remedies for patients with irreversible diseases of a myocardium: annually in the world more than 3000 similar operations are carried out. To the female patient of 61 years with a dilatation cardiomyopathy and an end-stage of a heart failure heart transplantation is carried in A.N. Bakoulev Scientific Center for Cardiovascular Surgery of Russian Academy of Medical Sciences through mechanical circulatory support system. Against the carried-out therapy it becomes perceptible positive dinamics on clinical and echocardiografic indicators.
References
1. Бокерия Л.А., Бокерия О.Л., Глушко Л.А. Метаанализ современных клинических исследований и отдаленные результаты применения сердечной ресинхронизирующей терапии. Анналы аритмологии. 2012; 1: 44—55.
2. Krabatsch Т., Schweiger М., Stepanenko А., Drews Т., Potapov Е., Paste М. et al. Improvements in implantable mechanical circulatory support systems: literature overview and update. Herz■ 2011; 36: 622-9.
3. Schulze PC., Jiang J., Yang J., Cheema F.H., Schaeffle K, Kato T.S. et al. Preoperative assessment of high risk candidates to predict survival following heart transplantation. Circ. Heart Fail. 2013; 15: 121-5.
4. Gregoty S.D., Timms D., Gaddum N., Mason D.G., Fraser J.F. Biventricular assist devices: a technical review. Ann. Biomed. Engineering. 2011; 39: 2313-28.
5. Павлов A.B., Полунин Г.В., Кузнецов B.A., Xa- рацВ.Е., Криночкин Д.В., Белоногов Д.В. Сердечная ресинхронизирующая терапия в лечении хронической сердечной недостаточности: отда
ленный период наблюдения. Анналы аритмологии. 2011; 1: 68-71.
6. MontAlveme D.G., Galdino Е.М., Pinheiro М.С., Eevy C.S., Vdsconceios G.G., Souza Neto J.D. et al. Clinical and functional capacity of patients with dilated cardiomyopathy after four years of transplantation. Rev. Bras. Cir. Cardiovasc. Des. 2012; 27: 562-9.
7. Fioreiii A.I., Coeiho G.H., Oliveira J.F., Oliveira S.A. Insuliciencia cardiaca e transplante cardiac. Rev. Med. 2008; 87: 105-20.
8. Gridelli B., Remuzzl G. Strategies for making more organs available for transplantation. N. Engl. J. Med. 2000; 343: 404-10.
